CNS Pharmaceuticals, Inc. Amortization of Deferred Charges
CNS Pharmaceuticals, Inc. (CNSP) reported Amortization of Deferred Charges of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2024-04-01
- CNS Pharmaceuticals, Inc. amortization of deferred charges for the quarter ending 2019-12-31 was $0.00.
- CNS Pharmaceuticals, Inc. amortization of deferred charges for the quarter ending 2018-12-31 was $0.00.
- CNS Pharmaceuticals, Inc. amortization of deferred charges for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CNS Pharmaceuticals, Inc. amortization of deferred charges for fiscal 2022 was $334.14K.
- CNS Pharmaceuticals, Inc. amortization of deferred charges for fiscal 2021 was $0.00.
- CNS Pharmaceuticals, Inc. amortization of deferred charges for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | ||
| 2022-12-31 | $334.14K 10-K · filed 2024-04-01 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2020-12-31 | $0.00 10-K · filed 2021-02-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $102.22K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $102.22K 10-Q · filed 2019-12-20 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |